Hyperkalaemia can be identified on an ECG by tall tented T waves, small or absent P waves, and broad bizarre QRS complexes. In severe cases, the QRS complexes may form a sinusoidal wave pattern, and asystole may occur. On the other hand, hypokalaemia can be detected by ST segment depression, prominent U waves, small or inverted T waves, a prolonged PR interval (which can also be present in hyperkalaemia), and a long QT interval.

Hyperkalaemia is a condition where there is an excess of potassium in the blood. The levels of potassium in the plasma are regulated by various factors such as aldosterone, insulin levels, and acid-base balance. When there is metabolic acidosis, hyperkalaemia can occur as hydrogen and potassium ions compete with each other for exchange with sodium ions across cell membranes and in the distal tubule. The ECG changes that can be seen in hyperkalaemia include tall-tented T waves, small P waves, widened QRS leading to a sinusoidal pattern, and asystole.

There are several causes of hyperkalaemia, including acute kidney injury, drugs such as potassium sparing diuretics, ACE inhibitors, angiotensin 2 receptor blockers, spironolactone, ciclosporin, and heparin, metabolic acidosis, Addison’s disease, rhabdomyolysis, and massive blood transfusion. Foods that are high in potassium include salt substitutes, bananas, oranges, kiwi fruit, avocado, spinach, and tomatoes.

It is important to note that beta-blockers can interfere with potassium transport into cells and potentially cause hyperkalaemia in renal failure patients. In contrast, beta-agonists such as Salbutamol are sometimes used as emergency treatment. Additionally, both unfractionated and low-molecular weight heparin can cause hyperkalaemia by inhibiting aldosterone secretion.

The patient’s painless hematuria and fatigue, combined with a history of smoking and occupation in a dye factory, suggest a diagnosis of transitional cell carcinoma of the bladder. This is supported by the observation of an abnormal growth in the bladder during ureteroscopy (First Aid 2017, p219 & p569).

1. Arsenic is a carcinogen that raises the risk of angiosarcoma of the liver, squamous cell carcinoma of the skin, and lung cancer.
2. Aromatic amines, such as 2-naphthylamine and benzidine, are carcinogens that increase the risk of transitional cell carcinoma of the bladder. They are commonly used in dye manufacturing.
3. Aflatoxins from Aspergillus increase the risk of hepatocellular carcinoma. Aflatoxins are frequently found in crops like peanuts and maize.
4. Nitrosamines in smoked foods are linked to an increased risk of stomach cancer.
5.

Risk Factors for Bladder Cancer

Bladder cancer is a type of cancer that affects the bladder, and there are different types of bladder cancer. The risk factors for urothelial (transitional cell) carcinoma of the bladder include smoking, which is the most important risk factor in western countries. Exposure to aniline dyes, such as working in the printing and textile industry, and rubber manufacture are also risk factors. Cyclophosphamide, a chemotherapy drug, is also a risk factor for this type of bladder cancer. On the other hand, the risk factors for squamous cell carcinoma of the bladder include schistosomiasis and smoking. It is important to be aware of these risk factors and take steps to reduce your risk of developing bladder cancer.

The primary intravesical immunotherapy for early-stage bladder cancer is Bacillus Calmette-Guerin (BCG), which does not pose a risk for bladder cancer. There is no evidence to suggest that aspirin has any impact on the risk of bladder cancer. However, exposure to hydrocarbons like 2-Naphthylamine is a known risk factor for bladder cancer.

Bladder cancer is a common urological cancer that primarily affects males aged 50-80 years old. Smoking and exposure to hydrocarbons increase the risk of developing the disease. Chronic bladder inflammation from Schistosomiasis infection is also a common cause of squamous cell carcinomas in countries where the disease is endemic. Benign tumors of the bladder, such as inverted urothelial papilloma and nephrogenic adenoma, are rare. The most common bladder malignancies are urothelial (transitional cell) carcinoma, squamous cell carcinoma, and adenocarcinoma. Urothelial carcinomas may be solitary or multifocal, with papillary growth patterns having a better prognosis. The remaining tumors may be of higher grade and prone to local invasion, resulting in a worse prognosis.

The TNM staging system is used to describe the extent of bladder cancer. Most patients present with painless, macroscopic hematuria, and a cystoscopy and biopsies or TURBT are used to provide a histological diagnosis and information on depth of invasion. Pelvic MRI and CT scanning are used to determine locoregional spread, and PET CT may be used to investigate nodes of uncertain significance. Treatment options include TURBT, intravesical chemotherapy, surgery (radical cystectomy and ileal conduit), and radical radiotherapy. The prognosis varies depending on the stage of the cancer, with T1 having a 90% survival rate and any T, N1-N2 having a 30% survival rate.

When a patient with nephrotic syndrome experiences symptoms such as those presented in this scenario, the possibility of a vascular event should be considered. The acute onset of symptoms and underlying renal disease suggest the need to differentiate between arterial and venous events, such as arterial thromboembolism or dissection and venous thromboembolism.

Nephrotic syndrome increases the risk of both venous and arterial thromboses due to the loss of coagulation factors and plasminogen, leading to a hypercoagulable state. In this case, the lack of a radial pulse and cool limb suggest arterial pathology, which is more strongly associated with the loss of antithrombin III than with renal loss of protein S.

Risk factors such as Factor V Leiden deficiency, the omission of low molecular weight heparin, and immobility in hospital are not specifically relevant to this case.

Possible Complications of Nephrotic Syndrome

Nephrotic syndrome is a condition that affects the kidneys, causing them to leak protein into the urine. This can lead to a number of complications, including an increased risk of thromboembolism, which is related to the loss of antithrombin III and plasminogen in the urine. This can result in deep vein thrombosis, pulmonary embolism, and renal vein thrombosis, which can cause a sudden deterioration in renal function.

Other complications of nephrotic syndrome include hyperlipidaemia, which can increase the risk of acute coronary syndrome, stroke, and other cardiovascular problems. Chronic kidney disease is also a possible complication, as is an increased risk of infection due to the loss of urinary immunoglobulin. Additionally, hypocalcaemia can occur due to the loss of vitamin D and binding protein in the urine.

It is important for individuals with nephrotic syndrome to be aware of these potential complications and to work closely with their healthcare providers to manage their condition and prevent further complications from occurring. Regular monitoring and treatment can help to minimize the risk of these complications and improve overall health outcomes.

Autosomal dominant polycystic kidney disease increases the risk of brain haemorrhage due to ruptured berry aneurysms.

Autosomal dominant polycystic kidney disease (ADPKD) is a commonly inherited kidney disease that affects 1 in 1,000 Caucasians. The disease is caused by mutations in two genes, PKD1 and PKD2, which produce polycystin-1 and polycystin-2 respectively. ADPKD type 1 accounts for 85% of cases, while ADPKD type 2 accounts for 15% of cases. ADPKD type 1 is caused by a mutation in the PKD1 gene on chromosome 16, while ADPKD type 2 is caused by a mutation in the PKD2 gene on chromosome 4. ADPKD type 1 tends to present with renal failure earlier than ADPKD type 2.

To screen for ADPKD in relatives of affected individuals, an abdominal ultrasound is recommended. The diagnostic criteria for ultrasound include the presence of two cysts, either unilateral or bilateral, if the individual is under 30 years old. If the individual is between 30-59 years old, two cysts in both kidneys are required for diagnosis. If the individual is over 60 years old, four cysts in both kidneys are necessary for diagnosis.

For some patients with ADPKD, tolvaptan, a vasopressin receptor 2 antagonist, may be an option to slow the progression of cyst development and renal insufficiency. However, NICE recommends tolvaptan only for adults with ADPKD who have chronic kidney disease stage 2 or 3 at the start of treatment, evidence of rapidly progressing disease, and if the company provides it with the agreed discount in the patient access scheme.

Renal stones are predominantly made up of calcium phosphate, and individuals with renal tubular acidosis are at a higher risk of developing them. Uric acid stones, which make up only 5-10% of cases, are often associated with malignancies.

Renal stones can be classified into different types based on their composition. Calcium oxalate stones are the most common, accounting for 85% of all calculi. These stones are formed due to hypercalciuria, hyperoxaluria, and hypocitraturia. They are radio-opaque and may also bind with uric acid stones. Cystine stones are rare and occur due to an inherited recessive disorder of transmembrane cystine transport. Uric acid stones are formed due to purine metabolism and may precipitate when urinary pH is low. Calcium phosphate stones are associated with renal tubular acidosis and high urinary pH. Struvite stones are formed from magnesium, ammonium, and phosphate and are associated with chronic infections. The pH of urine can help determine the type of stone present, with calcium phosphate stones forming in normal to alkaline urine, uric acid stones forming in acidic urine, and struvate stones forming in alkaline urine. Cystine stones form in normal urine pH.

In cases of acute kidney injury, it is important to identify and treat the underlying cause while preventing further deterioration. However, certain medications must be discontinued, including angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, NSAIDs, and diuretics. Therefore, candesartan, an angiotensin receptor blocker, should be stopped in this patient. On the other hand, amlodipine, a calcium channel blocker, and doxazosin, an alpha antagonist, are safe to continue in patients with acute kidney injury.

Acute kidney injury (AKI) is a condition where there is a reduction in renal function following an insult to the kidneys. It was previously known as acute renal failure and can result in long-term impaired kidney function or even death. AKI can be caused by prerenal, intrinsic, or postrenal factors. Patients with chronic kidney disease, other organ failure/chronic disease, a history of AKI, or who have used drugs with nephrotoxic potential are at an increased risk of developing AKI. To prevent AKI, patients at risk may be given IV fluids or have certain medications temporarily stopped.

The kidneys are responsible for maintaining fluid balance and homeostasis, so a reduced urine output or fluid overload may indicate AKI. Symptoms may not be present in early stages, but as renal failure progresses, patients may experience arrhythmias, pulmonary and peripheral edema, or features of uraemia. Blood tests such as urea and electrolytes can be used to detect AKI, and urinalysis and imaging may also be necessary.

Management of AKI is largely supportive, with careful fluid balance and medication review. Loop diuretics and low-dose dopamine are not recommended, but hyperkalaemia needs prompt treatment to avoid life-threatening arrhythmias. Renal replacement therapy may be necessary in severe cases. Patients with suspected AKI secondary to urinary obstruction require prompt review by a urologist, and specialist input from a nephrologist is required for cases where the cause is unknown or the AKI is severe.

Gynaecomastia is a common symptom of testicular cancer and is caused by an increased oestrogen:androgen ratio. This occurs because germ-cell tumours produce hCG, which causes Leydig cells to produce more oestradiol in relation to testosterone. Leydig cell tumours also directly secrete more oestradiol and convert additional androgen precursors to oestrogens. This results in a relative reduction in androgen concentration and an increased conversion of androgens to oestrogens.

Obesity can also cause gynaecomastia due to increased levels of aromatase, the enzyme responsible for the conversion of androgens to oestrogens. However, this is not the most likely cause in this case as the patient has not gained weight elsewhere and presents with symptoms of testicular cancer.

Undescended testis is a significant risk factor for testicular cancer, but it is not a direct cause of gynaecomastia. Similarly, a prolactinoma can cause breast enlargement in males, but it is not commonly associated with testicular cancer or gynaecomastia.

In summary, gynaecomastia in testicular cancer is caused by an increased oestrogen:androgen ratio, which can result from germ-cell or Leydig cell tumours. Other potential causes, such as obesity, undescended testis, or prolactinoma, are less likely in this clinical scenario.

Testicular cancer is a common type of cancer that affects men between the ages of 20 and 30. The majority of cases (95%) are germ-cell tumors, which can be further classified as seminomas or non-seminomas. Non-germ cell tumors, such as Leydig cell tumors and sarcomas, are less common. Risk factors for testicular cancer include infertility, cryptorchidism, family history, Klinefelter’s syndrome, and mumps orchitis. Symptoms may include a painless lump, pain, hydrocele, and gynaecomastia.

Tumour markers can be used to diagnose testicular cancer. For germ cell tumors, hCG may be elevated in seminomas, while AFP and/or beta-hCG are elevated in non-seminomas. LDH may also be elevated in germ cell tumors. Ultrasound is the first-line diagnostic tool.

Treatment for testicular cancer depends on the type and stage of the tumor. Orchidectomy, chemotherapy, and radiotherapy may be used. Prognosis is generally excellent, with a 5-year survival rate of around 95% for Stage I seminomas and 85% for Stage I teratomas.

If a young child with a history of fever and sore throat develops hematuria and proteinuria, it could be either acute post-streptococcal glomerulonephritis or IgA nephropathy. However, post-streptococcal glomerulonephritis usually presents 2 to 4 weeks after a group A streptococcus infection, while IgA nephropathy presents at the same time as the upper respiratory tract infection. This child has IgA nephropathy, also known as Berger disease (First Aid 2017, p564-566).

1. Acute post-streptococcal glomerulonephritis is associated with glomerular hypertrophy.
2. IgA nephropathy involves the proliferation of mesangial cells.
3. Immune complex deposits in mesangial cells are present in IgA nephropathy but can only be visualized with electron microscopy.
4. Thickening of the glomerular basement membrane is characteristic of diabetic nephropathy and membranous nephropathy, both types of nephrotic syndrome.
5. Diabetic nephropathy is associated with an expansion of the mesangial matrix.

Understanding IgA Nephropathy

IgA nephropathy, also known as Berger’s disease, is the most common cause of glomerulonephritis worldwide. It typically presents as macroscopic haematuria in young people following an upper respiratory tract infection. The condition is thought to be caused by mesangial deposition of IgA immune complexes, and there is considerable pathological overlap with Henoch-Schonlein purpura (HSP). Histology shows mesangial hypercellularity and positive immunofluorescence for IgA and C3.

Differentiating between IgA nephropathy and post-streptococcal glomerulonephritis is important. Post-streptococcal glomerulonephritis is associated with low complement levels and the main symptom is proteinuria, although haematuria can occur. There is typically an interval between URTI and the onset of renal problems in post-streptococcal glomerulonephritis.

Management of IgA nephropathy depends on the severity of the condition. If there is isolated hematuria, no or minimal proteinuria, and a normal glomerular filtration rate (GFR), no treatment is needed other than follow-up to check renal function. If there is persistent proteinuria and a normal or only slightly reduced GFR, initial treatment is with ACE inhibitors. If there is active disease or failure to respond to ACE inhibitors, immunosuppression with corticosteroids may be necessary.

The prognosis for IgA nephropathy varies. 25% of patients develop ESRF. Markers of good prognosis include frank haematuria, while markers of poor prognosis include male gender, proteinuria (especially > 2 g/day), hypertension, smoking, hyperlipidaemia, and ACE genotype DD.

Overall, understanding IgA nephropathy is important for proper diagnosis and management of the condition. Proper management can help improve outcomes and prevent progression to ESRF.

Bicalutamide is a medication that blocks the androgen receptor and is commonly used to treat prostate cancer. Abiraterone, on the other hand, is an androgen synthesis inhibitor that is prescribed to patients with metastatic prostate cancer who have not responded to androgen deprivation therapy. GnRH agonists like goserelin can also be used to treat prostate cancer by reducing the release of gonadotrophins and inhibiting androgen production. While cyproterone acetate is a steroidal anti-androgen, it is not as commonly used as non-steroidal anti-androgens like bicalutamide.

Prostate cancer management varies depending on the stage of the disease and the patient’s life expectancy and preferences. For localized prostate cancer (T1/T2), treatment options include active monitoring, watchful waiting, radical prostatectomy, and radiotherapy (external beam and brachytherapy). For localized advanced prostate cancer (T3/T4), options include hormonal therapy, radical prostatectomy, and radiotherapy. Patients may develop proctitis and are at increased risk of bladder, colon, and rectal cancer following radiotherapy for prostate cancer.

In cases of metastatic prostate cancer, reducing androgen levels is a key aim of treatment. A combination of approaches is often used, including anti-androgen therapy, synthetic GnRH agonist or antagonists, bicalutamide, cyproterone acetate, abiraterone, and bilateral orchidectomy. GnRH agonists, such as Goserelin (Zoladex), initially cause a rise in testosterone levels before falling to castration levels. To prevent a rise in testosterone, anti-androgens are often used to cover the initial therapy. GnRH antagonists, such as degarelix, are being evaluated to suppress testosterone while avoiding the flare phenomenon. Chemotherapy with docetaxel is also an option for the treatment of hormone-relapsed metastatic prostate cancer in patients who have no or mild symptoms after androgen deprivation therapy has failed, and before chemotherapy is indicated.

Familial Hypercholesterolaemia: Causes, Diagnosis, and Management

Familial hypercholesterolaemia (FH) is a genetic condition that affects approximately 1 in 500 people. It is an autosomal dominant disorder that results in high levels of LDL-cholesterol, which can lead to early cardiovascular disease if left untreated. FH is caused by mutations in the gene that encodes the LDL-receptor protein.

To diagnose FH, NICE recommends suspecting it as a possible diagnosis in adults with a total cholesterol level greater than 7.5 mmol/l and/or a personal or family history of premature coronary heart disease. For children of affected parents, testing should be arranged by age 10 if one parent is affected and by age 5 if both parents are affected.

The Simon Broome criteria are used for clinical diagnosis, which includes a total cholesterol level greater than 7.5 mmol/l and LDL-C greater than 4.9 mmol/l in adults or a total cholesterol level greater than 6.7 mmol/l and LDL-C greater than 4.0 mmol/l in children. Definite FH is diagnosed if there is tendon xanthoma in patients or first or second-degree relatives or DNA-based evidence of FH. Possible FH is diagnosed if there is a family history of myocardial infarction below age 50 years in second-degree relatives, below age 60 in first-degree relatives, or a family history of raised cholesterol levels.

Management of FH involves referral to a specialist lipid clinic and the use of high-dose statins as first-line treatment. CVD risk estimation using standard tables is not appropriate in FH as they do not accurately reflect the risk of CVD. First-degree relatives have a 50% chance of having the disorder and should be offered screening, including children who should be screened by the age of 10 years if there is one affected parent. Statins should be discontinued in women 3 months before conception due to the risk of congenital defects.

The left adrenal gland is slightly bigger than the right and has a crescent shape. Its concave side fits against the medial border of the upper part of the left kidney. The upper part is separated from the cardia of the stomach by the peritoneum of the omental bursa. The lower part is in contact with the pancreas and splenic artery and is not covered by peritoneum. On the front side, there is a hilum where the suprarenal vein comes out. The gland rests on the kidney on the lateral side and on the left crus of the diaphragm on the medial side.

Adrenal Gland Anatomy

The adrenal glands are located superomedially to the upper pole of each kidney. The right adrenal gland is posteriorly related to the diaphragm, inferiorly related to the kidney, medially related to the vena cava, and anteriorly related to the hepato-renal pouch and bare area of the liver. On the other hand, the left adrenal gland is postero-medially related to the crus of the diaphragm, inferiorly related to the pancreas and splenic vessels, and anteriorly related to the lesser sac and stomach.

The arterial supply of the adrenal glands is through the superior adrenal arteries from the inferior phrenic artery, middle adrenal arteries from the aorta, and inferior adrenal arteries from the renal arteries. The right adrenal gland drains via one central vein directly into the inferior vena cava, while the left adrenal gland drains via one central vein into the left renal vein.

In summary, the adrenal glands are small but important endocrine glands located above the kidneys. They have a unique blood supply and drainage system, and their location and relationships with other organs in the body are crucial for their proper functioning.

The water deprivation test is a diagnostic tool for investigating diabetes insipidus. The Short Synacthen test is utilized to diagnose Addison’s disease. Cranial diabetes insipidus can be treated with Desmopressin, while nephrogenic diabetes insipidus can be treated with thiazide diuretics.

Diabetes insipidus is a medical condition that can be caused by either a decreased secretion of antidiuretic hormone (ADH) from the pituitary gland (cranial DI) or an insensitivity to ADH (nephrogenic DI). Cranial DI can be caused by various factors such as head injury, pituitary surgery, and infiltrative diseases like sarcoidosis. On the other hand, nephrogenic DI can be caused by genetic factors, electrolyte imbalances, and certain medications like lithium and demeclocycline. The common symptoms of DI are excessive urination and thirst. Diagnosis is made through a water deprivation test and checking the osmolality of the urine. Treatment options include thiazides and a low salt/protein diet for nephrogenic DI, while central DI can be treated with desmopressin.

The vessel drains directly and is connected by a short pathway. If the sutures are not tied with caution, it could potentially detach from the IVC. In such a scenario, the recommended approach would be to use a Satinsky clamp and a 6/0 prolene suture to manage the injury.

Adrenal Gland Anatomy

The adrenal glands are located superomedially to the upper pole of each kidney. The right adrenal gland is posteriorly related to the diaphragm, inferiorly related to the kidney, medially related to the vena cava, and anteriorly related to the hepato-renal pouch and bare area of the liver. On the other hand, the left adrenal gland is postero-medially related to the crus of the diaphragm, inferiorly related to the pancreas and splenic vessels, and anteriorly related to the lesser sac and stomach.

The arterial supply of the adrenal glands is through the superior adrenal arteries from the inferior phrenic artery, middle adrenal arteries from the aorta, and inferior adrenal arteries from the renal arteries. The right adrenal gland drains via one central vein directly into the inferior vena cava, while the left adrenal gland drains via one central vein into the left renal vein.

In summary, the adrenal glands are small but important endocrine glands located above the kidneys. They have a unique blood supply and drainage system, and their location and relationships with other organs in the body are crucial for their proper functioning.

Breast cancers that are positive for oestrogen receptors can be treated by reducing oestrogen levels, which can lower the risk of recurrence. Aromatase inhibitors are commonly prescribed to postmenopausal women with oestrogen-positive breast cancer for a period of 5 years, but they can cause side effects such as a decrease in bone density and an increase in osteoporosis risk. Tamoxifen is another medication that can modulate the effect of oestrogen on the breast and is usually prescribed to premenopausal women. Letrozole, on the other hand, does not fall into this category and does not exhibit negative feedback on the HPO axis. Trastuzumab is a drug that binds to HER2 receptors and is used for breast cancers that have a positive HER2 receptor status. Letrozole may be given alongside this drug if the tumour is also oestrogen receptor positive. Letrozole is not a selective progesterone receptor modulator, unlike drugs such as ulipristal acetate.

The renin-angiotensin-aldosterone system is a complex system that regulates blood pressure and fluid balance in the body. The adrenal cortex is divided into three zones, each producing different hormones. The zona glomerulosa produces mineralocorticoids, mainly aldosterone, which helps regulate sodium and potassium levels in the body. Renin is an enzyme released by the renal juxtaglomerular cells in response to reduced renal perfusion, hyponatremia, and sympathetic nerve stimulation. It hydrolyses angiotensinogen to form angiotensin I, which is then converted to angiotensin II by angiotensin-converting enzyme in the lungs. Angiotensin II has various actions, including causing vasoconstriction, stimulating thirst, and increasing proximal tubule Na+/H+ activity. It also stimulates aldosterone and ADH release, which causes retention of Na+ in exchange for K+/H+ in the distal tubule.

Testes that are located outside of their normal embryological descent range are known as ectopic testes. These can be found in various locations such as the superficial inguinal pouch, base of the penis, femoral triangle, and perineum.

Common Testicular Disorders in Paediatric Urology

Testicular disorders are frequently encountered in paediatric urological practice. One of the most common conditions is cryptorchidism, which refers to the failure of the testicle to descend from the abdominal cavity into the scrotum. It is important to differentiate between a non-descended testis and a retractile testis. Ectopic testes are those that lie outside the normal path of embryological descent. Undescended testes occur in approximately 1% of male infants and should be placed in the scrotum after one year of age. Magnetic resonance imaging (MRI) may be used to locate intra-abdominal testes, but laparoscopy is often necessary in this age group. Testicular torsion is another common condition that presents with sudden onset of severe scrotal pain. Surgical exploration is the management of choice, and delay beyond six hours is associated with low salvage rates. Hydroceles, which are fluid-filled sacs in the scrotum or spermatic cord, may be treated with surgical ligation of the patent processus vaginalis or scrotal exploration in older children with cystic hydroceles.

Overall, prompt diagnosis and appropriate management of testicular disorders are crucial in paediatric urology to prevent long-term complications and ensure optimal outcomes for patients.

The vesicouterine venous plexus is responsible for draining the bladder in females, while the vesicoprostatic venous plexus serves the same function in males by connecting the prostatic venous plexus and vesical plexuses. The pampiniform plexus is responsible for draining the ovaries in females. It is important to note that the terms vesicorectal and vesicovaginal plexuses are not accurate anatomical structures, but rather refer to fistulas that may form between the bladder and nearby structures.

Bladder Anatomy and Innervation

The bladder is a three-sided pyramid-shaped organ located in the pelvic cavity. Its apex points towards the symphysis pubis, while the base lies anterior to the rectum or vagina. The bladder’s inferior aspect is retroperitoneal, while the superior aspect is covered by peritoneum. The trigone, the least mobile part of the bladder, contains the ureteric orifices and internal urethral orifice. The bladder’s blood supply comes from the superior and inferior vesical arteries, while venous drainage occurs through the vesicoprostatic or vesicouterine venous plexus. Lymphatic drainage occurs mainly to the external iliac and internal iliac nodes, with the obturator nodes also playing a role. The bladder is innervated by parasympathetic nerve fibers from the pelvic splanchnic nerves and sympathetic nerve fibers from L1 and L2 via the hypogastric nerve plexuses. The parasympathetic fibers cause detrusor muscle contraction, while the sympathetic fibers innervate the trigone muscle. The external urethral sphincter is under conscious control, and voiding occurs when the rate of neuronal firing to the detrusor muscle increases.

Understanding PSA Testing for Prostate Cancer

Prostate specific antigen (PSA) is an enzyme produced by the prostate gland that has become an important marker for prostate cancer. However, there is still much debate about its usefulness as a screening tool. The NHS Prostate Cancer Risk Management Programme (PCRMP) has published guidelines on how to handle requests for PSA testing in asymptomatic men. While a recent European trial showed a reduction in prostate cancer deaths, there is also a high risk of over-diagnosis and over-treatment. As a result, the National Screening Committee has decided not to introduce a prostate cancer screening programme yet, but rather allow men to make an informed choice.

PSA levels may be raised by various factors, including benign prostatic hyperplasia, prostatitis, ejaculation, vigorous exercise, urinary retention, and instrumentation of the urinary tract. However, PSA levels are not always a reliable indicator of prostate cancer. For example, around 20% of men with prostate cancer have a normal PSA level, while around 33% of men with a PSA level of 4-10 ng/ml will be found to have prostate cancer. To add greater meaning to a PSA level, age-adjusted upper limits and monitoring changes in PSA level over time (PSA velocity or PSA doubling time) are used. The PCRMP recommends age-adjusted upper limits for PSA levels, with a limit of 3.0 ng/ml for men aged 50-59 years, 4.0 ng/ml for men aged 60-69 years, and 5.0 ng/ml for men over 70 years old.

Hyponatremia is a common side effect of SSRIs, including Sertraline, which can cause SIADH. However, medications such as Statins, Levothyroxine, and Metformin are not typically linked to hyponatremia.

SIADH is a condition where the body retains too much water, leading to low sodium levels in the blood. This can be caused by various factors such as malignancy (particularly small cell lung cancer), neurological conditions like stroke or meningitis, infections like tuberculosis or pneumonia, certain drugs like sulfonylureas and SSRIs, and other factors like positive end-expiratory pressure and porphyrias. Treatment involves slowly correcting the sodium levels, restricting fluid intake, and using medications like demeclocycline or ADH receptor antagonists. It is important to correct the sodium levels slowly to avoid complications like central pontine myelinolysis.

Compartment syndrome can lead to necrosis of the proximal convoluted tubule, which plays a crucial role in reabsorbing up to two thirds of filtered water. Acute tubular necrosis is more likely to occur when systolic blood pressure falls below the renal autoregulatory range, particularly if it is low. However, within this range, the absolute value of systolic BP has minimal impact.

The Loop of Henle and its Role in Renal Physiology

The Loop of Henle is a crucial component of the renal system, located in the juxtamedullary nephrons and running deep into the medulla. Approximately 60 litres of water containing 9000 mmol sodium enters the descending limb of the loop of Henle in 24 hours. The osmolarity of fluid changes and is greatest at the tip of the papilla. The thin ascending limb is impermeable to water, but highly permeable to sodium and chloride ions. This loss means that at the beginning of the thick ascending limb the fluid is hypo osmotic compared with adjacent interstitial fluid. In the thick ascending limb, the reabsorption of sodium and chloride ions occurs by both facilitated and passive diffusion pathways. The loops of Henle are co-located with vasa recta, which have similar solute compositions to the surrounding extracellular fluid, preventing the diffusion and subsequent removal of this hypertonic fluid. The energy-dependent reabsorption of sodium and chloride in the thick ascending limb helps to maintain this osmotic gradient. Overall, the Loop of Henle plays a crucial role in regulating the concentration of solutes in the renal system.

The likely cause of the patient’s normal anion gap metabolic acidosis is diarrhoea. The anion gap calculation shows a normal range of 14 mmol/L, which is within the normal range of 8-14 mmol/L. Diarrhoea causes a loss of bicarbonate from the GI tract, resulting in less alkali to balance out the acid in the blood. Additionally, diarrhoea causes hypokalaemia due to potassium ion loss from the GI tract. COPD, Cushing’s syndrome, and diabetic ketoacidosis are incorrect options as they would result in respiratory acidosis, metabolic alkalosis, and raised anion gap metabolic acidosis, respectively.

Understanding Metabolic Acidosis

Metabolic acidosis is a condition that can be classified based on the anion gap, which is calculated by subtracting the sum of chloride and bicarbonate from the sum of sodium and potassium. The normal range for anion gap is 10-18 mmol/L. If a question provides the chloride level, it may be an indication to calculate the anion gap.

Hyperchloraemic metabolic acidosis is a type of metabolic acidosis with a normal anion gap. It can be caused by gastrointestinal bicarbonate loss, prolonged diarrhea, ureterosigmoidostomy, fistula, renal tubular acidosis, drugs like acetazolamide, ammonium chloride injection, and Addison’s disease. On the other hand, raised anion gap metabolic acidosis is caused by lactate, ketones, urate, acid poisoning, and other factors.

Lactic acidosis is a type of metabolic acidosis that is caused by high lactate levels. It can be further classified into two types: lactic acidosis type A, which is caused by sepsis, shock, hypoxia, and burns, and lactic acidosis type B, which is caused by metformin. Understanding the different types and causes of metabolic acidosis is important in diagnosing and treating the condition.

Complications that may arise after a transplant include CMV and EBV. CMV usually presents within the first 4 weeks to 6 months post transplant, while EBV can lead to post transplant lymphoproliferative disease, which typically occurs more than 6 months after the transplant. This disorder is often linked to high doses of immunosuppressant medication.

The HLA system, also known as the major histocompatibility complex (MHC), is located on chromosome 6 and is responsible for human leucocyte antigens. Class 1 antigens include A, B, and C, while class 2 antigens include DP, DQ, and DR. When matching for a renal transplant, the importance of HLA antigens is ranked as DR > B > A.

Graft survival rates for renal transplants are high, with a 90% survival rate at one year and a 60% survival rate at ten years for cadaveric transplants. Living-donor transplants have even higher survival rates, with a 95% survival rate at one year and a 70% survival rate at ten years. However, postoperative problems can occur, such as acute tubular necrosis of the graft, vascular thrombosis, urine leakage, and urinary tract infections.

Hyperacute rejection can occur within minutes to hours after a transplant and is caused by pre-existing antibodies against ABO or HLA antigens. This type of rejection is an example of a type II hypersensitivity reaction and leads to widespread thrombosis of graft vessels, resulting in ischemia and necrosis of the transplanted organ. Unfortunately, there is no treatment available for hyperacute rejection, and the graft must be removed.

Acute graft failure, which occurs within six months of a transplant, is usually due to mismatched HLA and is caused by cell-mediated cytotoxic T cells. This type of failure is usually asymptomatic and is detected by a rising creatinine, pyuria, and proteinuria. Other causes of acute graft failure include cytomegalovirus infection, but it may be reversible with steroids and immunosuppressants.

Chronic graft failure, which occurs after six months of a transplant, is caused by both antibody and cell-mediated mechanisms that lead to fibrosis of the transplanted kidney, known as chronic allograft nephropathy. The recurrence of the original renal disease, such as MCGN, IgA, or FSGS, can also cause chronic graft failure.

A seminoma is the most probable diagnosis for this man based on his age, symptoms, and normal levels of tumour markers. Teratomas and yolk sac tumours usually result in elevated AFP and HCG levels, which are not present in seminomas. Epididymo-orchitis does not cause painless irregular mass lesions.

Overview of Testicular Disorders

Testicular disorders can range from benign conditions to malignant tumors. Testicular cancer is the most common malignancy in men aged 20-30 years, with germ-cell tumors accounting for 95% of cases. Seminomas are the most common subtype, while non-seminomatous germ cell tumors include teratoma, yolk sac tumor, choriocarcinoma, and mixed germ cell tumors. Risk factors for testicular cancer include cryptorchidism, infertility, family history, Klinefelter’s syndrome, and mumps orchitis. The most common presenting symptom is a painless lump, but pain, hydrocele, and gynecomastia may also be present.

Benign testicular disorders include epididymo-orchitis, which is an acute inflammation of the epididymis often caused by bacterial infection. Testicular torsion, which results in testicular ischemia and necrosis, is most common in males aged between 10 and 30. Hydrocele presents as a mass that transilluminates and may occur as a result of a patent processus vaginalis in children. Treatment for these conditions varies, with orchidectomy being the primary treatment for testicular cancer. Surgical exploration is necessary for testicular torsion, while epididymo-orchitis and hydrocele may require medication or surgical procedures depending on the severity of the condition.

GnRH agonists used in the treatment of prostate cancer can paradoxically lead to lower LH levels in the long term. This is because chronic use of these agonists can result in overstimulation of GnRH receptors, which in turn disrupts endogenous hormonal feedback systems. While initially stimulating the production of LH/FSH and subsequent androgen production, chronic use of GnRH agonists can cause negative feedback to suppress the release of gonadotropins, resulting in a significant decrease in serum testosterone levels. This mechanism can be thought of as switching on to switch off. It is important to note that inhibiting the 5 alpha-reductase enzyme and relaxing prostatic smooth muscle are not mechanisms of action for GnRH agonists, but rather for other medications used in the treatment of prostate conditions.

Prostate cancer management varies depending on the stage of the disease and the patient’s life expectancy and preferences. For localized prostate cancer (T1/T2), treatment options include active monitoring, watchful waiting, radical prostatectomy, and radiotherapy (external beam and brachytherapy). For localized advanced prostate cancer (T3/T4), options include hormonal therapy, radical prostatectomy, and radiotherapy. Patients may develop proctitis and are at increased risk of bladder, colon, and rectal cancer following radiotherapy for prostate cancer.

In cases of metastatic prostate cancer, reducing androgen levels is a key aim of treatment. A combination of approaches is often used, including anti-androgen therapy, synthetic GnRH agonist or antagonists, bicalutamide, cyproterone acetate, abiraterone, and bilateral orchidectomy. GnRH agonists, such as Goserelin (Zoladex), initially cause a rise in testosterone levels before falling to castration levels. To prevent a rise in testosterone, anti-androgens are often used to cover the initial therapy. GnRH antagonists, such as degarelix, are being evaluated to suppress testosterone while avoiding the flare phenomenon. Chemotherapy with docetaxel is also an option for the treatment of hormone-relapsed metastatic prostate cancer in patients who have no or mild symptoms after androgen deprivation therapy has failed, and before chemotherapy is indicated.

Excessive alcohol consumption can result in the suppression of ADH in the posterior pituitary gland, which can lead to polyuria.

Normally, dehydration causes an increase in plasma osmolality, which triggers the release of vasopressin (antidiuretic hormone) from the posterior pituitary gland. This hormone increases the insertion of aquaporin 2 channels in the distal convoluted tubules and collecting duct in the kidney, which in turn increases water reabsorption. This leads to a decrease in plasma osmolality and a reduction in the volume of urine produced, i.e., antidiuretic.

However, alcohol inhibits this mechanism, resulting in polyuria and dehydration. Polyuria can then cause thirst, i.e., polydipsia.

It is important to note that the sugars in alcohol do not typically cause osmotic diuresis unless there is an underlying condition such as diabetes and hyperglycemia.

Polyuria, or excessive urination, can be caused by a variety of factors. A recent review in the BMJ categorizes these causes by their frequency of occurrence. The most common causes of polyuria include the use of diuretics, caffeine, and alcohol, as well as diabetes mellitus, lithium, and heart failure. Less common causes include hypercalcaemia and hyperthyroidism, while rare causes include chronic renal failure, primary polydipsia, and hypokalaemia. The least common cause of polyuria is diabetes insipidus, which occurs in less than 1 in 10,000 cases. It is important to note that while these frequencies may not align with exam questions, understanding the potential causes of polyuria can aid in diagnosis and treatment.

Hyperacute transplant rejection is a rapid rejection of a donor organ that can occur within minutes to hours after transplantation. This rejection is caused by pre-existing antibodies against ABO or HLA antigens in the donor organ. If the rejection is widespread, it can activate the coagulation cascade and lead to occlusive thrombosis of the donated organ. Donor organs are carefully matched to recipients to minimize the risk of rejection.

Mast cell degranulation is an allergic reaction that is mediated by IgE and results in the release of histamine.

Acute rejection occurs days to weeks after transplantation and is an inflammatory process against the donated organ. Immunosuppressives can be used to slow down this process.

Chronic rejection occurs months to years after transplantation and is characterized by atrophy of the organ and arteriosclerosis, rather than acute inflammatory processes.

Graft vs Host disease occurs when donor T-cells mount a cell-mediated response against host tissues. This can lead to cholestasis, jaundice, a widespread rash, and diarrhea. It typically occurs within the first year following transplantation.

The HLA system, also known as the major histocompatibility complex (MHC), is located on chromosome 6 and is responsible for human leucocyte antigens. Class 1 antigens include A, B, and C, while class 2 antigens include DP, DQ, and DR. When matching for a renal transplant, the importance of HLA antigens is ranked as DR > B > A.

Graft survival rates for renal transplants are high, with a 90% survival rate at one year and a 60% survival rate at ten years for cadaveric transplants. Living-donor transplants have even higher survival rates, with a 95% survival rate at one year and a 70% survival rate at ten years. However, postoperative problems can occur, such as acute tubular necrosis of the graft, vascular thrombosis, urine leakage, and urinary tract infections.

Hyperacute rejection can occur within minutes to hours after a transplant and is caused by pre-existing antibodies against ABO or HLA antigens. This type of rejection is an example of a type II hypersensitivity reaction and leads to widespread thrombosis of graft vessels, resulting in ischemia and necrosis of the transplanted organ. Unfortunately, there is no treatment available for hyperacute rejection, and the graft must be removed.

Acute graft failure, which occurs within six months of a transplant, is usually due to mismatched HLA and is caused by cell-mediated cytotoxic T cells. This type of failure is usually asymptomatic and is detected by a rising creatinine, pyuria, and proteinuria. Other causes of acute graft failure include cytomegalovirus infection, but it may be reversible with steroids and immunosuppressants.

Chronic graft failure, which occurs after six months of a transplant, is caused by both antibody and cell-mediated mechanisms that lead to fibrosis of the transplanted kidney, known as chronic allograft nephropathy. The recurrence of the original renal disease, such as MCGN, IgA, or FSGS, can also cause chronic graft failure.

Desmopressin is an effective treatment for central diabetes insipidus, which is a rare condition caused by damage or dysfunction of the posterior pituitary gland resulting in a lack of ADH production. Carbimazole is used to treat hyperthyroidism, while goserelin is used to treat prostate cancer. Indapamide, a thiazide-like diuretic, is used to manage hypertension and heart failure.

Diabetes insipidus is a medical condition that can be caused by either a decreased secretion of antidiuretic hormone (ADH) from the pituitary gland (cranial DI) or an insensitivity to ADH (nephrogenic DI). Cranial DI can be caused by various factors such as head injury, pituitary surgery, and infiltrative diseases like sarcoidosis. On the other hand, nephrogenic DI can be caused by genetic factors, electrolyte imbalances, and certain medications like lithium and demeclocycline. The common symptoms of DI are excessive urination and thirst. Diagnosis is made through a water deprivation test and checking the osmolality of the urine. Treatment options include thiazides and a low salt/protein diet for nephrogenic DI, while central DI can be treated with desmopressin.

The correct answer is IgA mediated small vessel vasculitis, specifically Henoch-Schonlein purpura (HSP). This condition is characterized by palpable purpura, arthralgia, abdominal pain, and haematuria, and typically affects children aged 4-6 years. HSP is often triggered by infections such as streptococcal pharyngitis, but can also be caused by other infections like Mycoplasma pneumoniae, Epstein-Barr virus, and adenovirus.

The other options are incorrect. ANCA-associated vasculitis typically involves the respiratory and ENT systems, which this child does not have. Cryoglobulinaemic vasculitis is associated with hepatitis C, haematological malignancies, and autoimmune disease, none of which are present in this case. Deficiency of von Willebrand factor cleaving protein is a feature of TTP, which is rare in children and typically presents with a low platelet count. ITP is another autoimmune condition that can present similarly to HSP, but can be differentiated by a low platelet count.

Understanding Henoch-Schonlein Purpura

Henoch-Schonlein purpura (HSP) is a type of small vessel vasculitis that is mediated by IgA. It is often associated with IgA nephropathy, also known as Berger’s disease. HSP is commonly observed in children following an infection.

The condition is characterized by a palpable purpuric rash, which is accompanied by localized oedema over the buttocks and extensor surfaces of the arms and legs. Other symptoms include abdominal pain and polyarthritis. In some cases, patients may also experience haematuria and renal failure, which are indicative of IgA nephropathy.

Treatment for HSP typically involves analgesia for arthralgia. While there is inconsistent evidence for the use of steroids and immunosuppressants, supportive care is generally recommended for patients with nephropathy. The prognosis for HSP is usually excellent, particularly in children without renal involvement. However, it is important to monitor blood pressure and urinalysis to detect any signs of progressive renal involvement. Approximately one-third of patients may experience a relapse.

In summary, Henoch-Schonlein purpura is a self-limiting condition that is often seen in children following an infection. While the symptoms can be uncomfortable, the prognosis is generally good. However, it is important to monitor patients for any signs of renal involvement and provide appropriate supportive care.

Renal cell cancer, also known as hypernephroma, is a primary renal neoplasm that accounts for 85% of cases. It originates from the proximal renal tubular epithelium and is commonly associated with smoking and conditions such as von Hippel-Lindau syndrome and tuberous sclerosis. The clear cell subtype is the most prevalent, comprising 75-85% of tumors.

Renal cell cancer is more common in middle-aged men and may present with classical symptoms such as haematuria, loin pain, and an abdominal mass. Other features include endocrine effects, such as the secretion of erythropoietin, parathyroid hormone-related protein, renin, and ACTH. Metastases are present in 25% of cases at presentation, and paraneoplastic syndromes such as Stauffer syndrome may also occur.

The T category criteria for renal cell cancer are based on tumor size and extent of invasion. Management options include partial or total nephrectomy, depending on the tumor size and extent of disease. Patients with a T1 tumor are typically offered a partial nephrectomy, while alpha-interferon and interleukin-2 may be used to reduce tumor size and treat metastases. Receptor tyrosine kinase inhibitors such as sorafenib and sunitinib have shown superior efficacy compared to interferon-alpha.

In summary, renal cell cancer is a common primary renal neoplasm that is associated with various risk factors and may present with classical symptoms and endocrine effects. Management options depend on the extent of disease and may include surgery and targeted therapies.

If the kidney is present, the adrenal gland will typically develop in its normal location instead of being absent.

The adrenal cortex, which secretes steroids, is derived from the mesoderm of the posterior abdominal wall and is first detected at 6 weeks’ gestation. The fetal cortex predominates throughout fetal life, with adult-type zona glomerulosa and fasciculata detected but making up only a small proportion of the gland. The adrenal medulla, which is responsible for producing adrenaline, is of ectodermal origin and arises from neural crest cells that migrate to the medial aspect of the developing cortex. The fetal adrenal gland is relatively large, but it rapidly regresses at birth, disappearing almost completely by age 1 year. By age 4-5 years, the permanent adult-type adrenal cortex has fully developed.

Anatomic anomalies of the adrenal gland may occur, such as agenesis of an adrenal gland being usually associated with ipsilateral agenesis of the kidney. Fused adrenal glands, whereby the two glands join across the midline posterior to the aorta, are also associated with a fused kidney. Adrenal hypoplasia can occur in two forms: hypoplasia or absence of the fetal cortex with a poorly formed medulla, or disorganized fetal cortex and medulla with no permanent cortex present. Adrenal heterotopia describes a normal adrenal gland in an abnormal location, such as within the renal or hepatic capsules. Accessory adrenal tissue, also known as adrenal rests, is most commonly located in the broad ligament or spermatic cord but can be found anywhere within the abdomen, and even intracranial adrenal rests have been reported.